Oral proteasomal inhibitors ixazomib, oprozomib, and delanzomib upregulate the function of organic anion transporter 3 (oat3): implications in oat3-mediated drug-drug interactions

HIGHLIGHTS

• who: Yunzhou Fan and colleagues from the Department of Pharmaceutics, Rutgers, The State University of New Jersey, Frelinghuysen Road, Piscataway have published the Article: Oral Proteasomal Inhibitors Ixazomib, Oprozomib, and Delanzomib Upregulate the Function of Organic Anion Transporter 3 (OAT3): Implications in OAT3-Mediated Drug-Drug Interactions, in the Journal: Pharmaceutics 2020, 12, x FOR PEER REVIEW of /2020/
• what: This study investigated the effects of and delanzomib on the expression and transport activity of and elucidated the underlying mechanisms. COS-7 cells and and HEK293 cells transporters used in the studies will provide the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.